Advanced Biomed Statistics
Total Valuation
Advanced Biomed has a market cap or net worth of $5.74 million. The enterprise value is $4.25 million.
Important Dates
The next estimated earnings date is Thursday, May 14, 2026, after market close.
| Earnings Date | May 14, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Advanced Biomed has 1.36 million shares outstanding. The number of shares has increased by 6.73% in one year.
| Current Share Class | 1.36M |
| Shares Outstanding | 1.36M |
| Shares Change (YoY) | +6.73% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 65.91% |
| Owned by Institutions (%) | 0.16% |
| Float | 465,161 |
Valuation Ratios
The trailing PE ratio is 1.19.
| PE Ratio | 1.19 |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.51 |
| P/TBV Ratio | 0.65 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | 0.97 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 8.56, with a Debt / Equity ratio of 0.08.
| Current Ratio | 8.56 |
| Quick Ratio | 2.15 |
| Debt / Equity | 0.08 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 80.18% and return on invested capital (ROIC) is -32.46%.
| Return on Equity (ROE) | 80.18% |
| Return on Assets (ROA) | -26.90% |
| Return on Invested Capital (ROIC) | -32.46% |
| Return on Capital Employed (ROCE) | -34.44% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | $141,469 |
| Employee Count | 31 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -94.38% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -94.38% |
| 50-Day Moving Average | 4.90 |
| 200-Day Moving Average | 8.48 |
| Relative Strength Index (RSI) | 48.41 |
| Average Volume (20 Days) | 353,257 |
Short Selling Information
The latest short interest is 12,832, so 0.94% of the outstanding shares have been sold short.
| Short Interest | 12,832 |
| Short Previous Month | 22,721 |
| Short % of Shares Out | 0.94% |
| Short % of Float | 2.76% |
| Short Ratio (days to cover) | 0.03 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -3.30M |
| Pretax Income | 4.05M |
| Net Income | 4.39M |
| EBITDA | -2.97M |
| EBIT | -3.30M |
| Earnings Per Share (EPS) | $4.11 |
Full Income StatementBalance Sheet
The company has $2.60 million in cash and $714,692 in debt, with a net cash position of $1.89 million or $1.39 per share.
| Cash & Cash Equivalents | 2.60M |
| Total Debt | 714,692 |
| Net Cash | 1.89M |
| Net Cash Per Share | $1.39 |
| Equity (Book Value) | 9.48M |
| Book Value Per Share | 8.76 |
| Working Capital | 9.48M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$6.08 million and capital expenditures -$37,041, giving a free cash flow of -$6.11 million.
| Operating Cash Flow | -6.08M |
| Capital Expenditures | -37,041 |
| Depreciation & Amortization | 333,507 |
| Net Borrowing | 57,231 |
| Free Cash Flow | -6.11M |
| FCF Per Share | -$4.48 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
